Search

Your search keyword '"Salomon, M."' showing total 2,005 results

Search Constraints

Start Over You searched for: Author "Salomon, M." Remove constraint Author: "Salomon, M."
Sorry, I don't understand your search. ×
2,005 results on '"Salomon, M."'

Search Results

4. A New Approach to Estimate Semi-Parametric Gaussian Mixtures of Regressions with Varying Mixing Proportions

7. Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice

8. Seeing the Trees From the Forest: Challenges in Subgroup Analysis-Based Guidelines in Oncology

10. Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor TherapyTopical BRAF Inhibitor for Anti-EGFR Toxicities

11. Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry

12. Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

13. Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study

14. High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic SignaturesSummary

19. Efficient Estimation and Validation of Shrinkage Estimators in Big Data Analytics

20. IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy

22. Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

24. Interim analysis (IA) of the giredestrant (G) + everolimus (EVERO) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC).

25. Development and validation of RSClin N+ tool for hormone receptor-positive (HR+), HER2-negative (HER2-), node-positive breast cancer.

27. Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies

29. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

30. Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice

31. A Novel EM-Type Algorithm to Estimate Semi-Parametric Mixtures of Partially Linear Models

32. Nanohertz Frequency Determination for the Gravity Probe B HF SQUID Signal

33. Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System

34. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

35. Delimitation of the Final Pit in Open Pit Mines Using the Pseudoflow Maximum Flow Algorithm: A Comparative Analysis of 1×5 and 1×9 Arcs.

38. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer

39. Why Is End-of-Life Spending So High? Evidence from Cancer Patients

44. LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

48. The Phototropin Family of Photoreceptors

49. Application of Multilayer Perceptron Neural Network in Geological Modeling of Categorical Variables: A Case Study in Peru.

50. An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019–2020

Catalog

Books, media, physical & digital resources